The human cytomegalovirus. (Q35143349)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782241%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

The human cytomegalovirus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782241%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782241%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Giorgio Gribaudo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782241%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

David Lembo

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782241%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1

Santo Landolfo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782241%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782241%20AND%20SRC:MED&resulttype=core&format=json

Pharmacology & Therapeutics

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782241%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782241%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782241%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

269-297

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782241%20AND%20SRC:MED&resulttype=core&format=json

Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Safety and immunogenicity of the Towne strain cytomegalovirus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Monitoring of human cytomegalovirus infections in pediatric bone marrow transplant recipients by nucleic acid sequence-based amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recov

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Proteins associated with purified human cytomegalovirus particles

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus tegument protein pp71 (ppUL82) enhances the infectivity of viral DNA and accelerates the infectious cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Treatment of AIDS-Associated Gastrointestinal Cytomegalovirus Infection with Foscarnet and Ganciclovir: A Randomized Comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

A subset of viral transcripts packaged within human cytomegalovirus particles

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus infection results in altered Cdk2 subcellular localization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Vaccines against human cytomegalovirus: time to test

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The Structure of the Human Placenta: Implications for Initiating and Defending Against Virus Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Structure of the human cytomegalovirus B capsid by electron cryomicroscopy and image reconstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulatio

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Murine cytomegalovirus infection induces cellular folylpolyglutamate synthetase activity in quiescent cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus encodes three G protein-coupled receptor homologues

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Susceptibility of human cytomegalovirus to cidofovir is unchanged after limited in vivo exposure to various regimens of drug

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Analysis of Interstrain Variation in Cytomegalovirus Glycoprotein B Sequences Encoding Neutralization-Related Epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Requirement for uracil-DNA glycosylase during the transition to late-phase cytomegalovirus DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Oral bioavailability of the antiretroviral agent 9-(2-phosphonylmethoxyethyl)adenine (PMEA) from three formulations of the prodrug bis(pivaloyloxymethyl)-PMEA in fasted male cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Analysis of the proliferative T cell response to human cytomegalovirus major immediate-early protein (IE1): phenotype, frequency and variability

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Fomivirsen - a phosphorothioate oligonucleotide for the treatment of CMV retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Vaccination of seropositive subjects with CHIRON CMV gB subunit vaccine combined with MF59 adjuvant for production of CMV immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Optimization of DNA immunization against human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Stimulation of Cellular Thymidine Kinases by Human Cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The outcome of congenital cytomegalovirus infection in relation to maternal antibody status

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfecting blood of an AIDS patient by an immediate-early antigen plaque assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Correlation of quantitative human cytomegalovirus pp65-, p72- and p150-antigenemia, viremia and circulating endothelial giant cells with clinical symptoms and antiviral treatment in immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Structure and assembly of the virion

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

vMIA, a viral inhibitor of apoptosis targeting mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Development of a cytomegalovirus vaccine: lessons from recent clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: the importance of the gB protein in HCMV immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Murine cytomegalovirus stimulates cellular thymidylate synthase gene expression in quiescent cells and requires the enzyme for replication

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus infection induces cellular thymidylate synthase gene expression in quiescent fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The 72K IE1 and 80K IE2 proteins of human cytomegalovirus independently trans-activate the c-fos, c-myc and hsp70 promoters via basal promoter elements

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Reduced Congenital Cytomegalovirus (CMV) Infection after Maternal Immunization with a Guinea Pig CMV Glycoprotein before Gestational Primary CMV Infection in the Guinea Pig Model

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

T cell proliferative responses to five human cytomegalovirus proteins in healthy seropositive individuals: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Immune evasion by cytomegalovirus--survival strategies of a highly adapted opportunist.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytomegalovirus glomerulopathy: a controversial lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Stimulation of Ornithine Decarboxylase by Human Cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytomegalovirus retinitis and viral resistance: ganciclovir resistance. CMV Retinitis and Viral Resistance Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Domain mapping of the human cytomegalovirus IE1-72 and cellular p107 protein-protein interaction and the possible functional consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Manipulation of the cell cycle by human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The human cytomegalovirus UL100 gene encodes the gC-II glycoproteins recognized by group 2 monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Molecular evolution of herpesviruses: genomic and protein sequence comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Provision of prognostic information in immunocompromised patients by routine application of the polymerase chain reaction for cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus latent infection of granulocyte-macrophage progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Randomized, Controlled Study of the Safety and Efficacy of Intravenous Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Antibodies to human cytomegalovirus structural polypeptides during primary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus stimulates cellular dihydrofolate reductase activity in quiescent cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Molecular analysis of the immune response to human cytomegalovirus glycoprotein B. I. Mapping of HLA-restricted helper T cell epitopes on gp93

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Antibodies to Recombinant-Derived Glycoprotein B after Natural Human Cytomegalovirus Infection Correlate with Neutralizing Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus origin of DNA replication (oriLyt) resides within a highly complex repetitive region

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Advances in the management of AIDS-related cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Regulation of human cytomegalovirus immediate-early gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Effect of a modulator deletion on transcription of the human cytomegalovirus major immediate-early genes in infected undifferentiated and differentiated cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Herpesvirus assembly and egress

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

In silico structural and functional analysis of the human cytomegalovirus (HHV5) genome.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Identification of a Viral Kinase That Phosphorylates Specific E2Fs and Pocket Proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Epidemiology and transmission of cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Specific Cell-Mediated Immunity and the Natural History of Congenital Infection with Cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Formation of Cytomegalovirus DNA Replication Compartments Defined by Localization of Viral Proteins and DNA Synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytomegalovirus encodes a potent alpha chemokine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cell types involved in replication and distribution of human cytomegalovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Clinical Trials of Immunization with the Towne 125 Strain of Human Cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Polymerase chain reaction for prenatal diagnosis of congenital human cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human Cytomegalovirus Immediate‐Early Messenger RNA in Blood of Pregnant Women with Primary Infection and of Congenitally Infected Newborns

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Maternal cytomegalovirus excretion and perinatal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Glomerulopathy Associated with Cytomegalovirus Viremia in Renal Allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

pIRS1 and pTRS1 are present in human cytomegalovirus virions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Preemptive Therapy in Immunocompromised Hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytomegalovirus is frequently isolated in bronchoalveolar lavage fluid of bone marrow transplant recipients without pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Reducing the Risk for Transfusion-transmitted Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Increased susceptibility to cytomegalovirus infection in beige mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus cell tropism and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Tissue macrophages are infected by human cytomegalovirus in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytomegalovirus Retinopathy as the Initial Manifestation of the Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Reactivation of Latent Human Cytomegalovirus by Allogeneic Stimulation of Blood Cells from Healthy Donors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Effect of the human cytomegalovirus IE86 protein on expression of E2F-responsive genes: a DNA microarray analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Potential role of human cytomegalovirus and p53 interaction in coronary restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Congenital cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Maternal Cytomegalovirus Infection and Perinatal Transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Do pathogens accelerate atherosclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Characterization of the signal peptide processing and membrane association of human cytomegalovirus glycoprotein O.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Randomized dose-comparison studies of intravitreous fomivirsen for treatment of cytomegalovirus retinitis that has reactivated or is persistently active despite other therapies in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Histopathology of early and late human hepatic allograft rejection: evidence of progressive destruction of interlobular bile ducts

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Transmission of cytomegalovirus to preterm infants through breast milk

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Treatment of cytomegalovirus diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytomegalovirus (CMV) infection, CD4+ lymphocyte counts and the development of AIDS in HIV-1-infected haemophiliac patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cytomegalovirus infections in heart and heart and lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Congenital Cytomegalovirus Infection Outcome for the Subsequent Sibling

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Induction of the transcription factor Sp1 during human cytomegalovirus infection mediates upregulation of the p65 and p105/p50 NF-kappaB promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Asymptomatic primary cytomegalovirus infection: virologic and immunologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: Induction of interferon-responsive RNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2803%2900034-2

7 January 2021

10.1016/S0163-7258(03)00034-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12782241%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference